Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy

Chad Brodt, Jill D. Siegfried, Mark Hofmeyer, Jose Martel, Evadnie Rampersaud, Duanxiang Li, Ana Morales, Ray E. Hershberger

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: LMNA cardiomyopathy presents with electrocardiogram (ECG) abnormalities, conduction system disease (CSD), and/or arrhythmias before the onset of dilated cardiomyopathy (DCM). Knowing the time interval between the onset of CSD and its progression to DCM would help to guide clinical care. Methods and Results: We evaluated family members from 16 pedigrees previously identified to carry LMNA mutations for the ages of onset of ECG abnormalities, CSD, or arrhythmia and of left ventricular enlargement (LVE) and/or systolic dysfunction. Of 103 subjects, 64 carried their family LMNA mutation, and 51 (79%) had ECG abnormalities with a mean age of onset of 41.2 years (range 18-76). Ventricular dysfunction was observed in 26 with a mean age of onset of 47.6 years (range 28-82); at diagnosis 9 had systolic dysfunction but no LVE, 5 had LVE but no systolic dysfunction, and 11 had DCM. Of 16 subjects identified with ECG abnormalities who later developed ventricular dysfunction, the median ages of onset by log-rank analyses were 41 and 48 years, respectively. Conclusions: ECG abnormalities preceded DCM with a median difference of 7 years. Clinical surveillance should occur at least annually in those at risk for LMNA cardiomyopathy with any ECG findings.

Original languageEnglish
Pages (from-to)233-239
Number of pages7
JournalJournal of Cardiac Failure
Volume19
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Ventricular Dysfunction
Cardiomyopathies
Electrocardiography
Dilated Cardiomyopathy
Age of Onset
Cardiac Arrhythmias
Mutation
Left Ventricular Dysfunction
Pedigree
Disease Progression

Keywords

  • Dilated cardiomypathy
  • genetics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Brodt, C., Siegfried, J. D., Hofmeyer, M., Martel, J., Rampersaud, E., Li, D., ... Hershberger, R. E. (2013). Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. Journal of Cardiac Failure, 19(4), 233-239. https://doi.org/10.1016/j.cardfail.2013.03.001

Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. / Brodt, Chad; Siegfried, Jill D.; Hofmeyer, Mark; Martel, Jose; Rampersaud, Evadnie; Li, Duanxiang; Morales, Ana; Hershberger, Ray E.

In: Journal of Cardiac Failure, Vol. 19, No. 4, 01.04.2013, p. 233-239.

Research output: Contribution to journalArticle

Brodt, C, Siegfried, JD, Hofmeyer, M, Martel, J, Rampersaud, E, Li, D, Morales, A & Hershberger, RE 2013, 'Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy', Journal of Cardiac Failure, vol. 19, no. 4, pp. 233-239. https://doi.org/10.1016/j.cardfail.2013.03.001
Brodt, Chad ; Siegfried, Jill D. ; Hofmeyer, Mark ; Martel, Jose ; Rampersaud, Evadnie ; Li, Duanxiang ; Morales, Ana ; Hershberger, Ray E. / Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. In: Journal of Cardiac Failure. 2013 ; Vol. 19, No. 4. pp. 233-239.
@article{76ffddd3217a4463aa6d1e4ef1e98b50,
title = "Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy",
abstract = "Background: LMNA cardiomyopathy presents with electrocardiogram (ECG) abnormalities, conduction system disease (CSD), and/or arrhythmias before the onset of dilated cardiomyopathy (DCM). Knowing the time interval between the onset of CSD and its progression to DCM would help to guide clinical care. Methods and Results: We evaluated family members from 16 pedigrees previously identified to carry LMNA mutations for the ages of onset of ECG abnormalities, CSD, or arrhythmia and of left ventricular enlargement (LVE) and/or systolic dysfunction. Of 103 subjects, 64 carried their family LMNA mutation, and 51 (79{\%}) had ECG abnormalities with a mean age of onset of 41.2 years (range 18-76). Ventricular dysfunction was observed in 26 with a mean age of onset of 47.6 years (range 28-82); at diagnosis 9 had systolic dysfunction but no LVE, 5 had LVE but no systolic dysfunction, and 11 had DCM. Of 16 subjects identified with ECG abnormalities who later developed ventricular dysfunction, the median ages of onset by log-rank analyses were 41 and 48 years, respectively. Conclusions: ECG abnormalities preceded DCM with a median difference of 7 years. Clinical surveillance should occur at least annually in those at risk for LMNA cardiomyopathy with any ECG findings.",
keywords = "Dilated cardiomypathy, genetics",
author = "Chad Brodt and Siegfried, {Jill D.} and Mark Hofmeyer and Jose Martel and Evadnie Rampersaud and Duanxiang Li and Ana Morales and Hershberger, {Ray E.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1016/j.cardfail.2013.03.001",
language = "English",
volume = "19",
pages = "233--239",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy

AU - Brodt, Chad

AU - Siegfried, Jill D.

AU - Hofmeyer, Mark

AU - Martel, Jose

AU - Rampersaud, Evadnie

AU - Li, Duanxiang

AU - Morales, Ana

AU - Hershberger, Ray E.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Background: LMNA cardiomyopathy presents with electrocardiogram (ECG) abnormalities, conduction system disease (CSD), and/or arrhythmias before the onset of dilated cardiomyopathy (DCM). Knowing the time interval between the onset of CSD and its progression to DCM would help to guide clinical care. Methods and Results: We evaluated family members from 16 pedigrees previously identified to carry LMNA mutations for the ages of onset of ECG abnormalities, CSD, or arrhythmia and of left ventricular enlargement (LVE) and/or systolic dysfunction. Of 103 subjects, 64 carried their family LMNA mutation, and 51 (79%) had ECG abnormalities with a mean age of onset of 41.2 years (range 18-76). Ventricular dysfunction was observed in 26 with a mean age of onset of 47.6 years (range 28-82); at diagnosis 9 had systolic dysfunction but no LVE, 5 had LVE but no systolic dysfunction, and 11 had DCM. Of 16 subjects identified with ECG abnormalities who later developed ventricular dysfunction, the median ages of onset by log-rank analyses were 41 and 48 years, respectively. Conclusions: ECG abnormalities preceded DCM with a median difference of 7 years. Clinical surveillance should occur at least annually in those at risk for LMNA cardiomyopathy with any ECG findings.

AB - Background: LMNA cardiomyopathy presents with electrocardiogram (ECG) abnormalities, conduction system disease (CSD), and/or arrhythmias before the onset of dilated cardiomyopathy (DCM). Knowing the time interval between the onset of CSD and its progression to DCM would help to guide clinical care. Methods and Results: We evaluated family members from 16 pedigrees previously identified to carry LMNA mutations for the ages of onset of ECG abnormalities, CSD, or arrhythmia and of left ventricular enlargement (LVE) and/or systolic dysfunction. Of 103 subjects, 64 carried their family LMNA mutation, and 51 (79%) had ECG abnormalities with a mean age of onset of 41.2 years (range 18-76). Ventricular dysfunction was observed in 26 with a mean age of onset of 47.6 years (range 28-82); at diagnosis 9 had systolic dysfunction but no LVE, 5 had LVE but no systolic dysfunction, and 11 had DCM. Of 16 subjects identified with ECG abnormalities who later developed ventricular dysfunction, the median ages of onset by log-rank analyses were 41 and 48 years, respectively. Conclusions: ECG abnormalities preceded DCM with a median difference of 7 years. Clinical surveillance should occur at least annually in those at risk for LMNA cardiomyopathy with any ECG findings.

KW - Dilated cardiomypathy

KW - genetics

UR - http://www.scopus.com/inward/record.url?scp=84876260987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876260987&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2013.03.001

DO - 10.1016/j.cardfail.2013.03.001

M3 - Article

VL - 19

SP - 233

EP - 239

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 4

ER -